Dr. Boden-Albala describes why involvement of diverse populations is critical to clinical trials, why inclusion remains suboptimal, and what we can do about it in this piece in Neuron, “Confronting legacies of underrepresentation in clinical trials: The case for greater diversity in research.”
Author: NIMICT Team
Visit NIMICT’s YouTube Channel Below is Researchers Discuss: How to Effectively Budget for Your Clinical Trial
NIMICT presented their survey results at the International Stroke Conference in San Diego, California February 12-14. Add visiting NIMICT’s poster to your itinerary.